Company intelligence / Profile preview

Pro2col Health

Tampa, Florida, United States

Ownership: Private
Development stage: Other

Overview

Pro2col Health developed a digital application to provide personalized nutrition recommendations using individual biometrics, supporting healthy, active lifestyles. Their platform is designed to deliver tailored health and longevity protocols. A beta version is expected for select users in Q3 2025 with full US release in Q4 2025 under Herbalife[1].

Therapeutic areas: Other
Modalities: Digital platform
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

HerbalifeLink BioSciences

Beyond the preview

Go deeper on Pro2col Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro2col Health.

Explore the full profile